[869572-92-9]    

MFCD11973644

Synonyms : 4-Trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop(f)isoindol-2(1H)-yl)-benzamide

Applications : Tecovirimat is a core protein cysteine protease inhibitor potentially for treatment of smallpox infection. Tecovirimat is a novel antiviral that inhibits the egress of orthopoxviruses by targeting viral p37 protein orthologs. Tecovirimat has shown efficacy in all small animal and nonhuman primate prophylaxis and therapeutic efficacy models of poxvirus-induced disease tested to date.

References : Lindholm D. A. et al.: Clin Infect Dis., 69(12), 2205-2207, 2019; Chan-Tack K. M. et al.: Lancet Infect Dis., 19(6), e221-e224, 2019; Laudisoit A. N. Engl J. Med., 379(21), 2084-2085, 2018; Russo A. T. et al.: J. Infect Dis., 218(9), 1490-1499, 2018; Grosenbach D. W. et al.: N. Engl J. Med., 379(1), 44-53, 2018; Berhanu A. et al.: Antimicrob Agents Chemother., 59(7), 4296-300, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.